h-header

news

News dal mondo

04

Mar

ECHA’s Risk Assessment Committee adopts its opinion on PFAS restriction proposal

The European Chemicals Agency’s (ECHA) Risk Assessment Committee (RAC) has concluded its evaluation of the universal restriction proposal on all per- and polyfluoroalkyl substances (PFAS). Its opinion is the first part of ECHA’s two-committee scientific evaluation of the proposal...[ECHA]

27

Apr

US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...

23

Apr

Top Drugs at Risk of Supply Shortages

Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...

23

Apr

Regulatory considerations for pharmaceutical excipient selection

The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...

21

Apr

TGA clarifies therapeutic goods are unaffected by chemical production and import ban

TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...

slider-banner

h-footer